ARTICLE | Discovery & Translation
Learning human biology: a Q&A with Genentech’s Nikhil Wagle
The head of Genentech’s two-year-old Translational Medicine unit on patient samples as a portal to discovery, precision and “custody of mechanism”
November 12, 2024 7:20 PM UTC
The growing ability to learn from patient samples begets the responsibility to do so, according to Genentech’s SVP and Global Head of Translational Medicine Nikhil Wagle.
Having joined the Genentech Inc. unit of Roche (SIX:ROG; OTCQB:RHHBY) from Broad Institute of MIT and Harvard in February of last year, Wagle runs the company’s two-year-old Translational Medicine department, which is responsible for the discovery, development and use of biomarkers across its entire pipeline...
BCIQ Company Profiles